Cheryl Garganta

1.0k total citations
28 papers, 745 citations indexed

About

Cheryl Garganta is a scholar working on Molecular Biology, Clinical Biochemistry and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Cheryl Garganta has authored 28 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Clinical Biochemistry and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Cheryl Garganta's work include Metabolism and Genetic Disorders (8 papers), Diet and metabolism studies (5 papers) and Vitamin D Research Studies (4 papers). Cheryl Garganta is often cited by papers focused on Metabolism and Genetic Disorders (8 papers), Diet and metabolism studies (5 papers) and Vitamin D Research Studies (4 papers). Cheryl Garganta collaborates with scholars based in United States, Canada and Germany. Cheryl Garganta's co-authors include Joann Bodurtha, Frank B. Hu, Jason Nelson, Bess Dawson‐Hughes, Anastassios G. Pittas, David M. Nathan, Joanna Mitri, Judith Bond, Barbara K. Burton and Stephen Cederbaum and has published in prestigious journals such as Analytical Chemistry, Diabetes Care and Analytical Biochemistry.

In The Last Decade

Cheryl Garganta

28 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheryl Garganta United States 15 249 212 196 158 114 28 745
James H. Tonsgard United States 20 455 1.8× 235 1.1× 110 0.6× 140 0.9× 238 2.1× 43 1.4k
Toru Momoi Japan 17 334 1.3× 155 0.7× 108 0.6× 147 0.9× 71 0.6× 40 921
Sema Kalkan Uçar Türkiye 14 205 0.8× 113 0.5× 41 0.2× 203 1.3× 99 0.9× 86 632
Guido Primiano Italy 16 429 1.7× 135 0.6× 69 0.4× 100 0.6× 48 0.4× 72 847
Claire E. Hills United Kingdom 20 712 2.9× 147 0.7× 286 1.5× 190 1.2× 19 0.2× 43 1.5k
Karen L. Ericson United States 21 426 1.7× 48 0.2× 203 1.0× 270 1.7× 463 4.1× 32 1.5k
P Dreyfus United States 18 205 0.8× 349 1.6× 130 0.7× 169 1.1× 255 2.2× 57 1.2k
Lance H. Rodan United States 17 285 1.1× 144 0.7× 29 0.1× 64 0.4× 64 0.6× 48 763
Chike Bellarmine Item Austria 17 348 1.4× 360 1.7× 38 0.2× 179 1.1× 132 1.2× 38 879
W. Endres Germany 20 471 1.9× 381 1.8× 35 0.2× 151 1.0× 278 2.4× 73 1.0k

Countries citing papers authored by Cheryl Garganta

Since Specialization
Citations

This map shows the geographic impact of Cheryl Garganta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Garganta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Garganta more than expected).

Fields of papers citing papers by Cheryl Garganta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Garganta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Garganta. The network helps show where Cheryl Garganta may publish in the future.

Co-authorship network of co-authors of Cheryl Garganta

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Garganta. A scholar is included among the top collaborators of Cheryl Garganta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Garganta. Cheryl Garganta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garganta, Cheryl, et al.. (2021). Rapid improvement of skin lesions in CHILD syndrome with topical 5% simvastatin ointment. Pediatric Dermatology. 39(1). 151–152. 5 indexed citations
2.
Richardson, Annely M., Gerard T. Berry, Cheryl Garganta, & Mary‐Alice Abbott. (2016). Hydroxysteroid 17-Beta Dehydrogenase Type 10 Disease in Siblings. JIMD Reports. 32. 25–32. 9 indexed citations
3.
Ceglia, Lisa, Jason Nelson, James S. Ware, et al.. (2015). Association between body weight and composition and plasma 25-hydroxyvitamin D level in the Diabetes Prevention Program. Zeitschrift für Ernährungswissenschaft. 56(1). 161–170. 27 indexed citations
4.
Zhang, Fang Fang, Jeffrey B. Driban, Grace H. Lo, et al.. (2014). Vitamin D Deficiency Is Associated with Progression of Knee Osteoarthritis. Journal of Nutrition. 144(12). 2002–2008. 83 indexed citations
5.
Mitri, Joanna, Jason Nelson, Robin Ruthazer, et al.. (2014). Plasma 25-hydroxyvitamin D and risk of metabolic syndrome: an ancillary analysis in the Diabetes Prevention Program. European Journal of Clinical Nutrition. 68(3). 376–383. 19 indexed citations
6.
Alroy, Joseph, et al.. (2014). Secondary biochemical and morphological consequences in lysosomal storage diseases. Biochemistry (Moscow). 79(7). 619–636. 13 indexed citations
7.
Sahai, Inderneel, Cheryl Garganta, Jeffrey A. Bailey, et al.. (2013). Newborn Screening for Glutaric Aciduria-II: The New England Experience. JIMD Reports. 13. 1–14. 12 indexed citations
8.
Driban, Jeffrey B., Grace H. Lo, Sarah L. Booth, et al.. (2013). Serum levels of vitamin D and parathyroid hormone and progression of knee OA: the osteoarthritis initiative study. Osteoarthritis and Cartilage. 21. S24–S25. 1 indexed citations
9.
Poduri, Annapurna, Vida Chitsazzadeh, Stefano D’Arrigo, et al.. (2009). The syndrome of perisylvian polymicrogyria with congenital arthrogryposis. Brain and Development. 32(7). 550–555. 13 indexed citations
10.
Arnold, Georgianne L., Johan Van Hove, Debra Freedenberg, et al.. (2009). A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiency. Molecular Genetics and Metabolism. 96(3). 85–90. 112 indexed citations
11.
Dericioğlu, Neşe, et al.. (2008). Blockade of GABA synthesis only affects neural excitability under activated conditions in rat hippocampal slices. Neurochemistry International. 53(1-2). 22–32. 15 indexed citations
12.
Arnold, Georgianne L., Dwight D. Koeberl, Dietrich Matern, et al.. (2007). A Delphi-based consensus clinical practice protocol for the diagnosis and management of 3-methylcrotonyl CoA carboxylase deficiency. Molecular Genetics and Metabolism. 93(4). 363–370. 46 indexed citations
13.
Garganta, Cheryl, et al.. (2005). Recurrent High Anion Gap Metabolic Acidosis Secondary to 5-Oxoproline (Pyroglutamic Acid). American Journal of Kidney Diseases. 46(1). e4–e10. 29 indexed citations
14.
Garganta, Cheryl & Wendy E. Smith. (2005). Metabolic Evaluation of the Sick Neonate. Seminars in Perinatology. 29(3). 164–172. 3 indexed citations
15.
Garganta, Cheryl, et al.. (2005). Assays for measuring extracellular GABA levels and cell migration rate in acute slices. Brain Research Protocols. 14(2). 126–134. 21 indexed citations
16.
Murakami, Tomoko, Kazuyoshi Fukai, Naoki Oiso, et al.. (2004). New KIT mutations in patients with piebaldism. Journal of Dermatological Science. 35(1). 29–33. 24 indexed citations
17.
Garganta, Cheryl & Margretta R. Seashore. (2000). Universal Screening for Congenital Hearing Loss. Pediatric Annals. 29(5). 302–308. 4 indexed citations
18.
Garganta, Cheryl & Barry Wolf. (1996). A Colorimetric Assay of Lipoyl-N-ϵ-Lysine Hydrolysis Activity Using 2,6-Dibromoquinone-4-Chlorimide. Analytical Biochemistry. 240(2). 177–184. 6 indexed citations
19.
Garganta, Cheryl & Joann Bodurtha. (1992). Report of another family with Simpson‐Golabi‐Behmel syndrome and a review of the literature. American Journal of Medical Genetics. 44(2). 129–135. 56 indexed citations
20.
Garganta, Cheryl & Barry Wolf. (1990). Lipoamidase activity in human serum is due to biotinidase. Clinica Chimica Acta. 189(3). 313–325. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James H. Tonsgard Breakdown of academic impact, for papers by Toru Momoi Breakdown of academic impact, for papers by Sema Kalkan Uçar Breakdown of academic impact, for papers by Guido Primiano Breakdown of academic impact, for papers by Claire E. Hills Breakdown of academic impact, for papers by Karen L. Ericson Breakdown of academic impact, for papers by P Dreyfus Breakdown of academic impact, for papers by Lance H. Rodan Breakdown of academic impact, for papers by Chike Bellarmine Item Breakdown of academic impact, for papers by W. Endres
Rankless by CCL
2026